Trihexyphenidyl: The Paradox of the Parkinson’s Pill

Trihexyphenidyl, almost exclusively known in India by the brand names Pacitane and Bexol, is a medication with a precise and vital clinical mission: to restore the balance of neurotransmitters in patients with Parkinson’s disease and to rescue those suffering from the painful muscle spasms (EPS) caused by older antipsychotics or antihistamines like Promethazine (Part 34). However, in the dark corners of the Indian pharmaceutical market, Trihexyphenidyl has a second, much more dangerous reputation. Known colloquially as “Five-Star” or “Pacit,” it is one of the most frequently misused anticholinergic drugs in the country. At high doses, it doesn’t just stop tremors; it induces a profound state of delirium and vivid hallucinations. In 2026, the domestic landscape for Trihexyphenidyl is defined by its transition to Schedule H1 status in several states, as authorities struggle to contain a “deliriant epidemic” that is increasingly leaving young users with permanent cognitive deficits and memory loss.

This thirty-eighth installment provides an exhaustive analysis of Trihexyphenidyl in the Indian context for 2026.

---

1. Substance Profile & Classification

• Generic Name: Trihexyphenidyl Hydrochloride (Benzhexol)
• Chemical Class: Tertiary Amine (Anticholinergic)
• Therapeutic Class: Antiparkinsonian Agent / Antimuscarinic
• Indian Legal Status:
  • Schedule H Drug: Technically a prescription-only medication.
  • Schedule H1 (Regional): In several high-risk states (Punjab, Manipur, Mizoram), Trihexyphenidyl has been moved to Schedule H1, requiring a special register for every sale to track the Aadhaar-linked prescription details of the buyer.
  • Regulatory Focus (2026): The CDSCO is auditing the production quotas of “Pacitane” due to reports of large-scale diversion from wholesale markets into the “street pharmacy” trade.

---

2. Market Availability and Pricing in India (May 2026)

Trihexyphenidyl is primarily available in India as 2mg tablets.

A. PMBJP (Jan Aushadhi Kendra) Availability

The Jan Aushadhi initiative provides Trihexyphenidyl to ensure that Parkinson’s patients have access to life-changing medication without the “branded” markup.

Medicine Name	Unit Size	Jan Aushadhi Price (INR)
Trihexyphenidyl Tablets IP 2 mg	10’s	₹6.50

B. Branded Market Prices (Commercial Sector)

Pfizer’s “Pacitane” is the most sought-after brand, often commanding a “premium” in the illicit market because of its perceived purity.

Brand Name	Manufacturer	Strength	Approx. Market Price (INR)
Pacitane	Pfizer India	2mg (10 Tabs)	₹38.00
Bexol	Intas Pharma	2mg (10 Tabs)	₹22.00
Parkin	Micro Labs	2mg (10 Tabs)	₹18.00
Triphen	Sun Pharma	2mg (10 Tabs)	₹25.00
Arkane	Abbott India	2mg (10 Tabs)	₹28.00

[!CAUTION] Street Pricing: While the MRP is low, “Pacitane” is often sold on the street for ₹500 to ₹1,000 per strip in regions where supply is restricted, highlighting its high abuse potential in 2026.

---

3. Clinical Pharmacology: The Acetylcholine Blockade

Mechanism of Action

Trihexyphenidyl is a potent competitive antagonist of muscarinic acetylcholine receptors.

• The Movement Fix: In Parkinson’s, there is a lack of dopamine, which causes a relative over-activity of acetylcholine. THP blocks this excess acetylcholine, stopping the tremors and rigidity.
• The Brain Impact: Acetylcholine is the brain’s “memory and reality” chemical. When you block it with high doses of THP, the brain loses its ability to filter out sensory input and maintain its “map” of reality.
• The Toxidrome: This leads to the “Anticholinergic Toxidrome” (discussed in Part 35), but THP is significantly more potent than Diphenhydramine.

Pharmacokinetics

• Onset: 1 hour.
• Duration: 6 to 12 hours.
• Metabolism: Primarily in the liver. It has a half-life of 3.3 to 4.1 hours, but its effects on the brain can linger for much longer in the form of “post-delirium fog.”

---

4. Euphoria and Misuse: The “Five-Star” High

The Euphoria Profile

• Low Dose: A mild sense of relaxation and “looseness.”
• High Dose (The High): Users often describe a “lightness” and a sense of being in a “dreamlike state.”
• The Delirium: At recreational doses (10mg - 20mg), users experience “true” hallucinations. Unlike the “trippy” colors of LSD, THP hallucinations are external and tangible—users will see people who aren’t there and hold long conversations with them, completely unaware that they are hallucinating.

Misuse Trends in India 2026

1. The “Five-Star” Cocktail: Mixing Pacitane with cheap “Quarter” bottles of whiskey or country liquor. This combination is common among manual laborers and street-involved youth.
2. The “Correction” Misuse: Using Pacitane to “manage” the bad side effects of other drugs, eventually leading to a dual addiction.
3. Prison/Incarceration Drug: Due to its small size and powerful effect, THP is a major contraband item in Indian prisons, where it is used to escape the psychological stress of confinement.

---

5. Critical Risks: Cognitive Collapse and Heatstroke

A. Early-Onset Cognitive Decline

Chronic misuse of Trihexyphenidyl literally “starves” the brain of the acetylcholine needed for memory. In 2026, Indian neurologists have noted a “dementia-like” state in long-term THP misusers as young as 30, characterized by an inability to form new memories and a permanent decline in IQ.

B. Anhidrosis (The Heat Risk)

THP stops the body’s ability to sweat. In the extreme heat of an Indian summer, a THP user is at a massive risk of Heatstroke because their body cannot cool itself down.

C. Narrow-Angle Glaucoma

THP causes the pupils to dilate significantly. In individuals with a certain eye structure, this can trigger an acute glaucoma attack—a medical emergency that can lead to permanent blindness within hours.

---

6. Toxicity and Overdose

Overdose Signs

• “Mad as a Hatter”: Violent agitation, screaming, and fighting with invisible entities.
• “Dry as a Bone”: Extremely high body temperature with bone-dry skin.
• “Blind as a Bat”: Pupils so dilated the iris is barely visible.
• Tachycardia: Heart rate exceeding 140 BPM, leading to possible cardiac arrest.

Emergency Action: Call 14446. Physostigmine is the antidote, but it is rarely available in rural Indian hospitals. Management is primarily supportive—sedation with benzodiazepines and cooling the body with ice packs.

---

7. Addiction and Recovery

• Tolerance: Develops within weeks. Users who started with 2mg may find themselves taking 10-15 tablets a day to feel “normal.”
• Withdrawal: Characterized by “rebound Parkinsonism” (severe tremors), extreme anxiety, and a “crawling” sensation under the skin.
• Recovery: Requires a very slow medical taper and intensive psychiatric support to manage the “brain fog” that follows cessation.

Resources for Help in India

• National Drug De-addiction Helpline: 14446
• NIMHANS: Bangalore (Movement Disorder Clinic).
• KIRAN Mental Health Helpline: 1800-599-0019

---

8. Harm Reduction Strategies

• The “Heat” Alert: If you are taking Trihexyphenidyl, stay in the shade and drink massive amounts of water. If you stop sweating in the heat, seek medical help immediately.
• The Eye Check: If you experience sudden eye pain or “halos” around lights after taking Pacitane, go to an ophthalmologist immediately.
• No Alcohol: Mixing THP with alcohol is a recipe for violent delirium and memory blackouts.
• Dental Care: The extreme dry mouth (Xerostomia) caused by THP leads to rapid tooth decay. Users must maintain strict oral hygiene and use saliva substitutes if possible.

---

9. Regulatory Outlook 2026

The CDSCO is considering a proposal to move all Trihexyphenidyl formulations to Schedule X, which would restrict its sale to only a handful of licensed pharmacies in each district, effectively treating it with the same level of control as Ketamine and Morphine.

---

Next in the Series: Part 39: Atropine – The ‘Deadly Nightshade’ and the Heart Rate Rescue

Disclaimer: This series is for educational and harm-reduction purposes only. Trihexyphenidyl is a potent anticholinergic medication with significant risks to cognitive health and eye safety. Use only as directed by a healthcare professional.